Clinical Trial

Central Sensitization Inventory and Symptoms of Pelvic Floor Dysfunctions

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated April 16, 2026 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to assess the values of Central Sensitization Inventory in women in a gynecology outpatient clinic. The main question it aims to answer is: Is there a relationship between outcomes of Central Sensitization Inventory and symptoms of pelvic floor dysfunctions reported by the patients? Participants will complete questionnaires: Central Sensitization Inventory and questionnaires assessing pelvic floor dysfunctions and their impact on quality of life (PFDI-20, PFIQ-7, PISQ-12).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-27; most recent amendment 2026-04-13.
Status change: Not Yet Recruiting → Enrolling by Invitation 2026-04-13
Trial Details
NCT Number NCT07154576
Lead Sponsor Żelazna Medical Centre, LLC
Conditions Pelvic Floor Dysfunctions
Enrollment 359 participants
Start Date 2025-10-28
Primary Completion 2026-05-30 (estimated)
Study Completion 2026-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-16